EXPRESSION OF A 32-KDA LIGAND FOR THE CD40 ANTIGEN ON ACTIVATED HUMAN T-LYMPHOCYTES

被引:66
|
作者
HERMANN, P [1 ]
BLANCHARD, D [1 ]
DESAINTVIS, B [1 ]
FOSSIEZ, F [1 ]
GAILLARD, C [1 ]
VANBERVLIET, B [1 ]
BRIERE, F [1 ]
BANCHEREAU, J [1 ]
GALIZZI, JP [1 ]
机构
[1] SCHERING PLOUGH CORP, IMMUNOL RES LAB, 27 CHEMIN PEUPLIERS, F-69571 DARDILLY, FRANCE
关键词
HUMAN T-LYMPHOCYTES; CD40; LIGAND;
D O I
10.1002/eji.1830230430
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To identify the ligand(s) of the human CD40 antigen, a cDNA encoding the extracellular domain of the CD40 antigen was fused to a cDNA encoding the constant region (Fc) of human IgG1. The CD40-Fc fusion protein was able to specifically bind to CD4+ and various CD8+ T cell clones activated with immobilized anti-CD3. The I-125-labeled CD40-Fc fusion protein bound anti-CD3 activated CD4+ T cell clone (MT9) with an equilibrium dissociation constant (K(d)) of 10-20 nM. The human CD40-binding protein expressed on the cell surface of activated T lymphocytes is a monomeric protein of almost-equal-to 32 kDa. Minor components of 29 kDa and 17 kDa were also detected. A small proportion of CD4+ and CD8+ blood mononuclear T cells activated by anti-CD3 expressed the CD40 ligand but its detection was best observed following depletion of B cells. Addition of B cells to purified T cells abolished the binding of CD40-Fc obtained after anti-CD3 activation.
引用
收藏
页码:961 / 964
页数:4
相关论文
共 50 条
  • [21] Luteolin, a flavonoid, inhibits CD40 ligand expression by activated human basophils
    Hirano, Toru
    Arimitsu, Junsuke
    Higa, Shinji
    Naka, Tetsuji
    Ogata, Atsushi
    Shima, Yoshihito
    Fujimoto, Minoru
    Yamadori, Tomoki
    Ohkawara, Tomoharu
    Kuwabara, Yusuke
    Kawai, Mari
    Kawase, Ichiro
    Tanaka, Toshio
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2006, 140 (02) : 150 - 156
  • [22] GAMMA/DELTA T-LYMPHOCYTES EXPRESS CD40 LIGAND AND CAN INDUCE ISOTYPE SWITCHING IN B-LYMPHOCYTES
    HORNER, AA
    RAMESH, N
    JABARA, H
    GEHA, RS
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1995, 95 (01) : 173 - 173
  • [23] The CD40 ligand directly activates T-lymphocytes via tyrosine phosphorylation dependent PKC activation
    Brenner, B
    Koppenhoefer, U
    LeppleWienhues, A
    Grassme, H
    Muller, C
    Speer, CP
    Lang, F
    Gulbins, E
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 239 (01) : 11 - 17
  • [24] The role of CD40/CD40 ligand interactions in the expression of OX40 ligand and 4.1 BB ligand in antigen presenting cells
    Schneider, N.
    Muller, C.
    Barabas, S.
    Lindner, J.
    Altmann, D.
    Wolf, W.
    Schblmerich, J.
    Fleck, M.
    Demi, L.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 : 46 - 46
  • [25] Heteromultimeric complexes of CD40 ligand are present on the cell surface of human T lymphocytes
    Hsu, YM
    Lucci, J
    Su, LH
    Ehrenfels, B
    Garber, E
    Thomas, D
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (02) : 911 - 915
  • [26] THE CD40 ANTIGEN AND ITS LIGAND
    BANCHEREAU, J
    BAZAN, F
    BLANCHARD, D
    BRIERE, F
    GALIZZI, JP
    VANKOOTEN, C
    LIU, YJ
    ROUSSET, F
    SAELAND, S
    ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 : 881 - 922
  • [27] Increased expression of CD40 ligand on activated T cells of patients with colon cancer
    Büning, C
    Krüger, K
    Sieber, T
    Schoeler, D
    Schriever, F
    CLINICAL CANCER RESEARCH, 2002, 8 (04) : 1147 - 1151
  • [28] In situ expression of CD40 and CD40 ligand in psoriasis
    Ohta, Y
    Hamada, Y
    DERMATOLOGY, 2004, 209 (01) : 21 - 28
  • [29] LPAP, A NOVEL 32-KDA PHOSPHOPROTEIN THAT INTERACTS WITH CD45 IN HUMAN-LYMPHOCYTES
    SCHRAVEN, B
    SCHOENHAUT, D
    BRUYNS, E
    KORETZKY, G
    ECKERSKORN, C
    WALLICH, R
    KIRCHGESSNER, H
    SAKORAFAS, P
    LABKOVSKY, B
    RATNOFSKY, S
    MEUER, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (46) : 29102 - 29111
  • [30] Regulation of CD40 ligand (CD154) mRNA turnover in human T lymphocytes.
    Rigby, WFC
    Waugh, MG
    Hamilton, BJ
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S263 - S263